首页> 外文OA文献 >Streamlining the preparation of “endotoxin-free” ClearColi cell extract with autoinduction media for cell-free protein synthesis of the therapeutic protein crisantaspase
【2h】

Streamlining the preparation of “endotoxin-free” ClearColi cell extract with autoinduction media for cell-free protein synthesis of the therapeutic protein crisantaspase

机译:用自动化介质简化制备“无毒素”透明细胞提取物,用于治疗蛋白质混凝酶的无细胞蛋白质合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An “endotoxin-free” E. coli-based cell-free protein synthesis system has been reported to produce therapeutic proteins rapidly and on-demand. However, preparation of the most complex CFPS reagent – the cell extract – remains time-consuming and labor-intensive because of the relatively slow growth kinetics of the endotoxin-free ClearColiTMBL21(DE3) strain. Here we report a streamlined procedure for preparing E. coli cell extract from ClearColi™ using auto-induction media. In this work, the term auto-induction describes cell culture media which eliminates the need for manual induction of protein expression. Culturing Clearcoli™ cells in autoinduction media significantly reduces the hands-on time required during extract preparation, and the resulting “endotoxin-free” cell extract maintained the same cell-free protein synthesis capability as extract produced with traditional induction as demonstrated by the high-yield expression of crisantaspase, an FDA approved leukemia therapeutic. It is anticipated that this work will lower the barrier for researchers to enter the field and use this technology as the method to produce endotoxin-free E. coli-based extract for CFPS. Keywords: Auto-induction, Autoinduction, Cell-free protein synthesis, CFPS, Endotoxin-free, Crisantaspase, Clearcoli
机译:据报道,“无毒素无毒素”大肠杆菌的无细胞蛋白质合成系统迅速和按需产生治疗蛋白。然而,制备最复杂的CFP试剂 - 细胞提取物 - 由于内毒素免疫溶液21(DE3)菌株的相对缓慢的生长动力学,仍然耗时和劳动密集型。在这里,我们报告了使用自动感应介质从ClearColi™制备大肠杆菌细胞提取物的简化程序。在这项工作中,术语自身诱导描述了细胞培养基,其消除了对蛋白质表达的手动诱导的需要。在自动化培养基中培养Clearcoli™细胞显着降低提取物制剂所需的动手时间,并且所得的“内毒素无”细胞提取物保持与用传统诱导产生的提取物的无细胞蛋白质合成能力,如高 - Crisantspase的产量表达,FDA批准的白血病治疗。预计这项工作将降低研究人员的障碍,进入该领域,并使用该技术作为生产内毒素无大肠杆菌的CO.CFPS提取物的方法。关键词:自身诱导,自动化,无细胞蛋白质合成,CFP,无内毒素,克切酶,熟人

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号